A novel high-throughput ex vivo ovine skin wound model for testing emerging antibiotics
A novel high-throughput ex vivo ovine skin wound model for testing emerging antibiotics
The development of antimicrobials is an expensive process with increasingly low success rates, which makes further investment in antimicrobial discovery research less attractive. Antimicrobial drug discovery and subsequent commercialization can be made more lucrative if a fail-fast-and-fail-cheap approach can be implemented within the lead optimization stages where researchers have greater control over drug design and formulation. In this article, the setup of an ex vivo ovine wounded skin model infected with Staphylococcus aureus is described, which is simple, cost-effective, high throughput, and reproducible. The bacterial physiology in the model mimics that during infection as bacterial proliferation is dependent on the pathogen's ability to damage the tissue. The establishment of wound infection is verified by an increase in viable bacterial counts compared to the inoculum. This model can be used as a platform to test the efficacy of emerging antimicrobials in the lead optimization stage. It can be contended that the availability of this model will provide researchers developing antimicrobials with a fail-fast-and-fail-cheap model, which will help increase success rates in subsequent animal trials. The model will also facilitate the reduction and refinement of animal use for research and ultimately enable faster and more cost-effective translation of novel antimicrobials for skin and soft tissue infections to the clinic.
Regan, Hannah C.
7cde0b64-b09d-4846-b465-235b26c57a1d
Taylor, Annette F.
08028a29-428d-4732-b6b1-f7a93389b386
Karunakaran, Esther
cc879001-f1d8-4996-9ab5-c88c22ebb246
16 September 2022
Regan, Hannah C.
7cde0b64-b09d-4846-b465-235b26c57a1d
Taylor, Annette F.
08028a29-428d-4732-b6b1-f7a93389b386
Karunakaran, Esther
cc879001-f1d8-4996-9ab5-c88c22ebb246
Regan, Hannah C., Taylor, Annette F. and Karunakaran, Esther
(2022)
A novel high-throughput ex vivo ovine skin wound model for testing emerging antibiotics.
Journal of Visualized Experiments, 187, [e64041].
(doi:10.3791/64041).
Abstract
The development of antimicrobials is an expensive process with increasingly low success rates, which makes further investment in antimicrobial discovery research less attractive. Antimicrobial drug discovery and subsequent commercialization can be made more lucrative if a fail-fast-and-fail-cheap approach can be implemented within the lead optimization stages where researchers have greater control over drug design and formulation. In this article, the setup of an ex vivo ovine wounded skin model infected with Staphylococcus aureus is described, which is simple, cost-effective, high throughput, and reproducible. The bacterial physiology in the model mimics that during infection as bacterial proliferation is dependent on the pathogen's ability to damage the tissue. The establishment of wound infection is verified by an increase in viable bacterial counts compared to the inoculum. This model can be used as a platform to test the efficacy of emerging antimicrobials in the lead optimization stage. It can be contended that the availability of this model will provide researchers developing antimicrobials with a fail-fast-and-fail-cheap model, which will help increase success rates in subsequent animal trials. The model will also facilitate the reduction and refinement of animal use for research and ultimately enable faster and more cost-effective translation of novel antimicrobials for skin and soft tissue infections to the clinic.
This record has no associated files available for download.
More information
Published date: 16 September 2022
Identifiers
Local EPrints ID: 499573
URI: http://eprints.soton.ac.uk/id/eprint/499573
ISSN: 1940-087X
PURE UUID: 8fcbd868-e2b8-4fe2-8177-8179119bca6f
Catalogue record
Date deposited: 27 Mar 2025 17:32
Last modified: 28 Mar 2025 03:15
Export record
Altmetrics
Contributors
Author:
Hannah C. Regan
Author:
Annette F. Taylor
Author:
Esther Karunakaran
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics